BCPC — BALCHEM CORP

Nasdaq · Materials · Chemicals · CIK 9326 ·
Last close
$177.50
Market Cap
$5.66B
52W High
$182.79
52W Low
$152.91
ADV30
183,857
Next earnings
2026-10-20
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Jun 2026
Mar 2026 270,709,000 101,084,000 55,626,000 40,285,000 1,693,742,000 72,873,000 408,626,000
Dec 2025 263,617,000 93,899,000 52,290,000 39,225,000 1,686,252,000 74,570,000 428,839,000
Sep 2025 267,558,000 95,453,000 54,579,000 40,289,000 1,661,031,000 65,093,000 363,167,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$220,160,000
Investing CF
$-44,271,000
Financing CF
$-155,624,000
CapEx
$-44,182,000
Dividends Paid
$-30,793,000
Buybacks
$-118,001,000
EPS Diluted TTM
$5.09
As of
2026-08-02

Balance + Analyst (yfinance extras)

Retained Earnings
$1,161,681,000
Inventory
$146,743,000
Receivables
$154,232,000
ST Investments
EBIT TTM
$213,120,000
Pretax Income TTM
$203,612,000
Interest Exp TTM
$9,508,000
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,085,880,960
EBITDA
$269,412,000
Free Cash Flow
$134,847,504
Enterprise Value
$5,882,388,480
Total Cash
$63,174,000
Total Debt
$166,715,008
Shares Out
31,878,021
Trailing EPS
$5.07
Book Value
$40.76
ROE
12.8%
ROA
8.2%
Div Yield
0.53%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,037,161,000 209,326,000 154,845,000 1,686,252,000 428,839,000 216,556,000
Dec 2024 953,684,000 182,909,000 128,475,000 1,575,371,000 425,458,000 181,999,000
Dec 2023 922,439,000 159,193,000 108,543,000 1,597,211,000 543,227,000 183,761,000
Dec 2022 942,358,000 145,186,000 105,367,000 1,624,512,000 686,228,000 138,536,000

TTM Snapshot

Revenues TTM
$239,940,000
NetIncome TTM
$33,837,000
OpCashFlow TTM
$0
Assets (Latest)
$1,575,371,000
Forward EPS
$6.27

Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)

max pain strike: $150.00 · spot: $177.50 · call volume: 60 · put volume: 10
Expected Move to 2026-11-20: ±$31.88 (17.96%) — implied range $145.62$209.38 · ATM straddle on $175.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
DFTX Definium Therapeutics, Inc. $5.81B $43.27
SXT SENSIENT TECHNOLOGIES CORP $5.85B $137.45
CSW CSW INDUSTRIALS, INC. $5.34B $327.56
ELF e.l.f. Beauty, Inc. $6.25B $105.95
PRM Perimeter Solutions, Inc. $5.02B $30.66

News headlines (Yahoo Finance, 1h cache)

Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026
2026-07-17 11:00 · Yahoo
Are Options Traders Betting on a Big Move in Balchem Stock?
2026-05-19 15:24 · Yahoo
Balchem Corp.’s (BCPC) 8% Top-Line Growth Proves Resilience Amid Macro Risk
2026-08-06 13:04 · Yahoo
Balchem Corporation Q2 2026 Earnings Call Summary
2026-07-31 20:50 · Yahoo
Beyond Oil: Record Revenue & U.S. Direct-Sales Expansion Fuel Scaling Phase – Quarterly Update Report
2026-08-18 17:19 · Yahoo
Balchem Corp (BCPC) (Q2 2026) Earnings Call Highlights: Record Sales and 28th Consecutive ...
2026-07-31 23:01 · Yahoo
Balchem Corporation Reports Second Quarter 2026 Financial Results
2026-07-31 11:00 · Yahoo
Hudbay Minerals Expands Constancia Mill Capacity With Permit Approval
2026-07-03 12:33 · Yahoo
Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
2026-06-26 11:00 · Yahoo
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
2026-05-27 11:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.